CIK: 0001609251 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 16, 2022
Total Value ($000): $302,495 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 201,228 | $47,417 | 15.7% | $121.76 | +67.0% | COM | 91307C102 |
| ALKS | ALKERMES PLC | 1,398,159 | $41,651 | 13.8% | $18.73 | +53.3% | COM | G01767105 |
| REGN | REGENERON PHARMACEUTICALS | 60,384 | $35,695 | 11.8% | $342.96 | +88.5% | COM | 75886F107 |
| EXEL | EXELIXIS INC | 1,506,885 | $31,373 | 10.4% | $18.77 | +9.8% | COM | 30161Q104 |
| ENTA | ENANTA PHARMACEUTICALS INC | 624,768 | $29,533 | 9.8% | $45.84 | +18.4% | COM | 29251M106 |
| MCK | MCKESSON CORP | 82,894 | $27,041 | 8.9% | $138.18 | +127.3% | COM | 58155Q103 |
| EMBC | EMBECTA CORP | 1,017,194 | $25,755 | 8.5% | $25.42 | 0.0% | COM | 29082K105 |
| BIIB | BIOGEN INC | 117,248 | $23,912 | 7.9% | $299.87 | -31.8% | COM | 09062X103 |
| — | TARO PHARMACEUTICAL INDUS | 580,524 | $20,992 | 6.9% | $75.44 | — | COM | M8737E108 |
| CAH | CARDINAL HEALTH INC | 178,839 | $9,348 | 3.1% | $52.39 | +0.5% | COM | 14149Y108 |
| EGRX | EAGLE PHARMACEUTICALS INC | 121,014 | $5,377 | 1.8% | $44.36 | +3.5% | COM | 269796108 |
| KOD | KODIAK SCIENCES INC | 554,192 | $4,234 | 1.4% | $33.04 | -78.7% | COM | 50015M109 |
| — | NEXTCURE INC | 30,999 | $146 | 0.0% | $9.88 | — | COM | 65343E108 |
| — | ASSEMBLY BIOSCIENCES INC | 9,985 | $21 | 0.0% | $2.08 | — | COM | 045396108 |